Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Anesthesiology
Published in: BMC Anesthesiology 1/2017

Open Access 01-12-2017 | Research article

Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis

Authors: Qin Wu, Xiaomeng Xu, Jianan Ren, Song Liu, Xuelian Liao, Xiuwen Wu, Dong Hu, Gefei Wang, Guosheng Gu, Yan Kang, Jieshou Li

Published in: BMC Anesthesiology | Issue 1/2017

Login to get access

Abstract

Background

The association between CD14-159C/T polymorphism and sepsis has been assessed but results of current studies appeared conflicting and inconstant. This analysis was aimed to determine whether the CD14-159C/T polymorphism confers susceptibility to sepsis or is associated with increased risk of death from sepsis.

Method

The authors conducted a comprehensive search of PubMed, EMBASE, ISI Web of Science, Cochrane library, ScienceDirect, Wiley Online Library and CNKI databases according to a prespecified protocol. Language limits were restricted to English and Chinese. Two reviewers independently selected the articles and extracted relevant data onto standardized forms. Disagreements were settled by discussion and suggestions from senior consultants. The strength of association were evaluated by odds ratio (OR) and 95% confidence interval (CI). Studies failed to fit the Hardy-Weinberg-Equilibrium were excluded.

Results

The research identified a total of 2317 full-text articles of which 14 articles met the predefined inclusion criteria. Meta-analysis was performed for allele frequency of C versus T, as well as genotypes CC + CT versus TT (dominant model), CC versus TT + CT (recessive model), CT versus TT and CC versus TT (additive model). All control samples were in Hardy-Weinberg proportion. No significant association between CD14-159C/T polymorphism and sepsis susceptibility or mortality were detected in the overall population. Nonetheless, subgroup analysis of Asian ethnicity revealed significant association between the CD14-159C/T polymorphism and susceptibility to sepsis in additive model (CC versus TT: OR = 0.52, 95% CI 0.29–0.92, p = 0.03) and recessive model (CC versus CT + TT: OR = 0.50, 95% CI 0.30–0.84, p = 0.009). Of note, three out of the five papers included in the subgroup focused exclusively on burn ICU patients.

Conclusions

This meta-analysis demonstrated that CD14-159C/T polymorphism is likely to be associated with susceptibility to sepsis in Asian population, especially for the TT genotype. However, bias may rise for etiologic reasons because the majority of subjects in the subgroup came from burn ICU. CD14-159C/T polymorphism is not relevant to sepsis mortality in any genetic models, regardless of the ethnicities. Due to the exploratory nature of the study, no adjustment for multiple testing was adopted, and therefore the results should be interpreted with precaution. Well-designed studies with larger sample size and more ethnic groups are required to further validate the results.
Appendix
Available only for authorised users
Literature
1.
Shankar-Hari M, Phillips GS, Levy ML, et al. Developing a New Definition and Assessing New Clinical Criteria for Septic Shock: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:775–87.CrossRefPubMedPubMedCentral
2.
Wu Q, Hu D, Ren J. Chronic critical illness should be considered in long-term mortality study among critical illness patients. Crit Care Med. 2015;43(2):e57.CrossRefPubMed
3.
Sapru A, Quasney MW. Host genetics and pediatric sepsis. Open Inflamm J. 2011;4(SPEC. ISS. 1):82–100.
4.
5.
6.
Garnacho Montero J, Garnacho Montero MC, Ortiz Leyba C, Aldabo Pallas T. Genetic polymorphisms in sepsis. Med Intensiva. 2005;29(3):185–91.CrossRef
7.
Spiegler J, Gopel W, Hartel C, Herting E. Sepsis and necrotizing enterocolitis in a large neonatal research network. Eur J Pediatr. 2010;169(3):392.
8.
Haziot A, Rong GW, Lin X-Y, Silver J, Goyert SM. Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). J Immunol. 1995;154(12):6529–32.PubMed
9.
Koury M, Puskarich M, Montgomery S, Jones A. Single nucleotide polymorphisms in emergency department patients with repeated admissions for sepsis. Acad Emerg Med. 2013;20(5):S304–5.
10.
Zhang AQ, Yue CL, Gu W, Du J, Wang HY, Jiang J. Association between CD14 promoter -159C/T polymorphism and the risk of sepsis and mortality: a systematic review and meta-analysis. PLoS One. 2013;8(8):e71237.CrossRefPubMedPubMedCentral
11.
Plantinga TS, Ioana M, Alonso S, Izagirre N, Hervella M, Joosten LA, van der Meer JW, de la Rua C, Netea MG. The evolutionary history of TLR4 polymorphisms in Europe. J Innate Immun. 2012;4(2):168–75.CrossRefPubMed
12.
Rajasekhar A, Lottenberg R, Lottenberg L, Liu H, Ang D. Pulmonary embolism prophylaxis with inferior vena cava filters in trauma patients: a systematic review using the meta-analysis of observational studies in epidemiology (MOOSE) guidelines. J Thromb Thrombolysis. 2011;32(1):40–6.CrossRefPubMed
13.
Ziegler A, Van Steen K, Wellek S. Investigating Hardy-Weinberg equilibrium in case-control or cohort studies or meta-analysis. Breast Cancer Res Treat. 2011;128(1):197–201.CrossRefPubMed
14.
Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol. 2005;11(28):4409–13.CrossRefPubMedPubMedCentral
15.
Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest. 1992;101(6):1644–55.CrossRefPubMed
16.
Fallavena PRV, Borges TJ, Paskulin DD, Paludo FJO, Goetze TB, De Oliveira JR, Nobrega OT, Dias FS, Alho CS. The influences of CD14–260C > T polymorphism on survival in ICU critically ill patients. Immunol Investig. 2009;38(8):797–811.CrossRef
17.
Dahmer MK, Randolph A, Vitali S, Quasney MW. Genetic polymorphisms in sepsis. Pediatr Crit Care Med. 2005;6(3 Suppl):S61–73.CrossRefPubMed
18.
Wu Q, Ren J, Hu D, Jiang P, Li G, Anjum N, Wang G, Gu G, Chen J, Wu X, et al. An elevated percentage of reticulated platelet is associated with increased mortality in septic shock patients. Medicine (Baltimore). 2015;94(19):e814.CrossRef
19.
Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem. 1999;274(16):10689–92.CrossRefPubMed
20.
Hubacek JA, Rothe G, Pit’ha J, Skodova Z, Stanek V, Poledne R, Schmitz G. C(−260)-- > T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction. Circulation. 1999;99(25):3218–20.CrossRefPubMed
21.
Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 1990;249(4975):1431–3.CrossRefPubMed
22.
Gibot S, Cariou A, Drouet L, Rossignol M, Ripoll L. Association between a genomic polymorphism within the CD14 locus and septic shock susceptibility and mortality rate*. Crit Care Med. 2002;30(5):969–73.CrossRefPubMed
23.
Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, Ikonomopoulos J, Gorgoulis VG. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol. 2005;11(5):681–5.CrossRefPubMedPubMedCentral
24.
Ng SC, Tsoi KK, Kamm MA, Xia B, Wu J, Chan FK, Sung JJ. Genetics of inflammatory bowel disease in Asia: Systematic review and meta‐analysis. Inflamm Bowel Dis. 2012;18(6):1164–76.CrossRefPubMed
25.
Heesen M, Bloemeke B, Schade U, Obertacke U, Majetschak M. The −260 C-- > T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients. Intensive Care Med. 2002;28(8):1161–3.CrossRefPubMed
26.
Hubacek JA, Stuber F, Frohlich D, Book M, Wetegrove S, Rothe G, Schmitz G. The common functional C(−159)T polymorphism within the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality. Genes Immun. 2000;1(6):405–7.CrossRefPubMed
27.
Kumpf O, Schumann RR. Genetic variation in innate immunity pathways and their potential contribution to the SIRS/CARS debate: Evidence from human studies and animal models. J Innate Immun. 2010;2(5):381–94.CrossRefPubMed
28.
Barber RC, Aragaki CC, Chang LY, Purdue GF, Hunt JL, Arnoldo BD, Horton JW. CD14-159 C allele is associated with increased risk of mortality after burn injury. Shock. 2007;27(3):232–7.CrossRefPubMed
29.
Gu W, Dong H, Jiang DP, Zhou J, Du DY, Gao JM, Yao YZ, Zhang LY, Wen AQ, Liu Q, et al. Functional significance of CD14 promoter polymorphisms and their clinical relevance in a Chinese Han population. Crit Care Med. 2008;36(8):2274–80.CrossRefPubMed
30.
D’Avila LC, Albarus MH, Franco CR, Aguiar BB, Oliveira JR, Dias FS, Alho CS. Effect of CD14–260C > T polymorphism on the mortality of critically ill patients. Immunol Cell Biol. 2006;84(4):342–8.CrossRefPubMed
31.
Barber RC, Aragaki CC, Rivera-Chavez FA, Purdue GF, Hunt JL, Horton JW. TLR4 and TNF-alpha polymorphisms are associated with an increased risk for severe sepsis following burn injury. J Med Genet. 2004;41(11):808–13.CrossRefPubMedPubMedCentral
32.
Lin J, Yao YM, Huang ZH, Hou XX, Zhu JM, Chai JK. Association between a genomic polymorphism within the CD14 locus and severe sepsis susceptibility as well as prognosis in patients after extensive burns. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2004;16(5):271–3.PubMed
33.
Bronkhorst MWGA, Boye NDA, Lomax MAZ, Vossen RHAM, Bakker J, Patka P, Van Lieshout EMM. Single-nucleotide polymorphisms in the Toll-like receptor pathway increase susceptibility to infections in severely injured trauma patients. J Trauma Acute Care Surg. 2013;74(3):862–70.CrossRefPubMed
34.
Dong N, Yao YM, Yu Y, Cao YJ, Sheng ZY. Distribution and clinical significance of CD14 promoter-159C/T polymorphism in patients with extensive burn. Zhonghua Shao Shang Za Zhi. 2009;25(2):115–8.PubMed
35.
Dong N, Yao YM, Huang XJ, He LX, Yu Y, Sheng ZY. Influence of CD14 gene polymorphism on the expression of high mobility group box-1 protein in patients with severe burn. Zhonghua Shao Shang Za Zhi. 2010;26(2):109–12.PubMed
36.
37.
38.
Tiancha H, Huiqin W, Jiyong J, Jingfen J, Wei C. Association between lymphotoxin-α intron + 252 polymorphism and sepsis: A meta-analysis. Scand J Infect Dis. 2011;43(6–7):436–47.CrossRefPubMed
39.
Jessen KM, Lindboe SB, Petersen AL, Eugen-Olsen J, Benfield T. Common TNF-alpha, IL-1 beta, PAI-1, uPA, CD14 and TLR4 polymorphisms are not associated with disease severity or outcome from Gram negative sepsis. BMC Infect Dis. 2007;7:108.CrossRefPubMedPubMedCentral
40.
Nakada T, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, Watanabe E, Abe R, Hatano M, Tokuhisa T. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res. 2005;129(2):322–8.CrossRefPubMed
41.
Shimada T, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Watanabe E, Abe R, Nakada TA, Tateishi Y, Otani S, et al. Outcome prediction in sepsis combined use of genetic polymorphisms–A study in Japanese population. Cytokine. 2011;54(1):79–84.CrossRefPubMed
Metadata
Title
Association between the -159C/T polymorphism in the promoter region of the CD14 gene and sepsis: a meta-analysis
Authors
Qin Wu
Xiaomeng Xu
Jianan Ren
Song Liu
Xuelian Liao
Xiuwen Wu
Dong Hu
Gefei Wang
Guosheng Gu
Yan Kang
Jieshou Li
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2017
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-017-0303-9

Other articles of this Issue 1/2017

BMC Anesthesiology 1/2017 Go to the issue

Research article

Patients with glycogen storage diseases undergoing anesthesia: a case series

Research article

Comparison of the Supreme™ and ProSeal™ laryngeal mask airways in infants: a prospective randomised clinical study

Research article

Effect of ultrasonography and fluoroscopic guidance on the incidence of complications of cannulation in extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a retrospective observational study

Research article

Association between cardiopulmonary resuscitation duration and one-month neurological outcomes for out-of-hospital cardiac arrest: a prospective cohort study

Research article

A comparison of the use of propofol alone and propofol with midazolam for pediatric magnetic resonance imaging sedation – a retrospective cohort study

Research article

Leg elevation decreases the incidence of post-spinal hypotension in cesarean section: a randomized controlled trial